Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PAX compared with TAK: revenue, margins and what each company keeps, and the suppliers and customers both name
PAX
Patria Investments Ltd
Change
Mkt cap
Revenue
Revenue
TAK
Takeda Pharmaceutical Co Ltd
Change
Mkt cap
Revenue
Revenue
vs
Compare
PAX
Patria Investments Ltd
vs
TAK
Takeda Pharmaceutical Co Ltd
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
PAX
Patria Investments Ltd
Change
9.18
▼
−1.29%
· post 9.18
Mkt cap
$1.5B
TAK
Takeda Pharmaceutical Co Ltd
Change
20.92
▲
+4.55%
· post 20.93
Closed
Oct 30 '26
Mkt cap
$36.0B
vs
Compare
Closed
Oct 30 '26
PAX
Patria Investments Ltd
vs
TAK
Takeda Pharmaceutical Co Ltd
9.18
▼
−1.29%
post 9.18
Price
20.92
▲
+4.55%
post 20.93
$1.5B
Mkt cap
$36.0B
Change
Change
PAX
9.18
▼
−1.29%
vs
TAK
20.92
▲
+4.55%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PAX, solid
TAK, dashed
Supply-chain overlap
Revenue flow
PAX: latest quarter not drawable. TAK: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PAX
13
—
KPMG Auditores Independentes Ltda
unlisted
supplier
—
Maples Corporate Services
unlisted
supplier
—
Nasdaq Global Select Market
unlisted
supplier
—
The Depository Trust
unlisted
supplier
9 more · PAX chain
›
Shared
0
No shared counterparties.
Only TAK
17
NBIX
Neurocrine Biosciences
customer
EXEL
Exelixis
supplier
PTGX
Protagonist Therapeutics
supplier
DNLI
Denali Therapeutics
supplier
13 more · TAK chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR